cobaltiprotoporphyrin has been researched along with Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Fakih, TM; Kurniawan, F; Mudasir, M; Tjahjono, DH; Yusuf, M | 1 |
Bolós, M; Coso, OA; Cuadrado, A; de Sagarra, MR; Marinissen, MJ; Tanos, T | 1 |
2 other study(ies) available for cobaltiprotoporphyrin and Neoplasms
Article | Year |
---|---|
Molecular Dynamics of Cobalt Protoporphyrin Antagonism of the Cancer Suppressor REV-ERBβ.
Topics: Binding Sites; Chemistry, Pharmaceutical; Cobalt; Heme; Humans; Iron; Kinetics; Ligands; Metals; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Neoplasms; Peptides; Photosensitizing Agents; Porphyrins; Protein Binding; Protoporphyrins; Receptors, Cytoplasmic and Nuclear; Repressor Proteins; Signal Transduction | 2021 |
Inhibition of heme oxygenase-1 interferes with the transforming activity of the Kaposi sarcoma herpesvirus-encoded G protein-coupled receptor.
Topics: Animals; Annexin A5; Apoptosis; Blotting, Western; Cell Proliferation; Cell Survival; Culture Media, Serum-Free; DNA; Dose-Response Relationship, Drug; Endothelial Cells; Enzyme Inhibitors; Fibroblasts; Fluorescent Antibody Technique, Indirect; Genes, Reporter; Heme; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Herpesvirus 8, Human; Immunohistochemistry; Luciferases; Metalloporphyrins; Mice; Mice, Nude; Models, Biological; Neoplasm Transplantation; Neoplasms; NIH 3T3 Cells; Promoter Regions, Genetic; Protoporphyrins; Receptors, G-Protein-Coupled; Reverse Transcriptase Polymerase Chain Reaction; RNA; RNA, Messenger; Time Factors; Transfection; Up-Regulation; Vascular Endothelial Growth Factor A | 2006 |